SAS MEDICS LIMITED

Executive Summary

SAS MEDICS LIMITED exhibits a stable and improving financial condition characterized by strong liquidity and growing net assets. The company is well-positioned operationally within its micro-entity scale, with no immediate financial distress symptoms. Continued prudent financial management and strategic growth planning will support sustained financial wellness.

SAS MEDICS LIMITED - Analysis Report

Company Number: 14047067

Analysis Date: 2025-07-20 16:57 UTC

Financial Health Assessment of SAS MEDICS LIMITED

---

1. Financial Health Score: B

Explanation: SAS MEDICS LIMITED shows a solid financial footing for a micro-entity in its early years. The company has demonstrated growth in net assets and working capital, indicating improving liquidity and financial stability. However, the scale is small, and fixed assets are minimal, reflecting a simple operational structure. The company’s financial "vital signs" suggest good health but warrant cautious monitoring as the business scales.

---

2. Key Vital Signs

Metric	2024 (£)	2023 (£)	Interpretation
Fixed Assets	2,005	0	Small investment in equipment; healthy for a micro company.
Current Assets	25,853	38,886	Decline but still healthy cash/debtors.
Current Liabilities	6,931	26,967	Significant reduction in short-term debts; positive "symptom" of liquidity improvement.
Net Current Assets	18,922	11,919	Strong working capital, indicating liquidity buffer.
Net Assets / Shareholders’ Funds	20,927	11,919	Growth in equity shows retained earnings or capital injection; a good sign of financial "vitality".
Employee Count	1	1	Small headcount consistent with micro category.

Additional Notes:

• Liquidity: The company has a healthy current ratio (~3.7 in 2024), indicating good short-term financial health and ability to pay off liabilities.
• Profitability: Although detailed P&L data is not reported here, the increase in net assets suggests profitable operations or capital contributions.
• Going Concern: Directors affirm confidence in ongoing operations, indicating management’s positive outlook.
• Asset Base: Minimal fixed assets, typical for a service or property management business.
• Filing Compliance: No overdue filings or penalties; good governance symptom.

---

3. Diagnosis: What the Financial Data Reveals

The company is in a stable and improving financial condition, with clear signs of healthy liquidity and growing equity. The reduction in current liabilities and increase in net current assets indicate the company is managing its short-term obligations well, akin to a patient showing strong pulse and stable vitals after initial treatment.

The increase in net assets from £11,919 to £20,927 over 12 months points to either retained profits or new capital injections, a positive recovery or growth signal. The small fixed asset base is consistent with the company’s business model and size, reflecting no over-investment in illiquid assets.

No worrying symptoms such as high debt ratios, negative working capital, or overdue filings are present. The company appears well-managed financially under its current scale and operational scope.

---

4. Recommendations: Specific Actions to Improve Financial Wellness

• Maintain Strong Working Capital: Continue monitoring current assets and liabilities to sustain liquidity. Avoid letting current liabilities rise sharply as the business grows.
• Build Profit History & Reporting: Consider preparing fuller profit and loss accounts for internal review, even if not required by micro-entity rules, to better track profitability trends.
• Plan for Asset Investment Prudently: Fixed assets remain low; consider strategic investment in tangible or intangible assets only if aligned with growth plans.
• Cash Flow Management: Keep a close eye on cash flow cycles, especially given the reduction in current assets from £38,886 to £25,853, to avoid liquidity stress.
• Governance and Compliance: Continue timely filing of accounts and confirmation statements to avoid penalties and preserve company reputation.
• Business Growth Strategy: With a solid financial base, explore opportunities for scaling while monitoring financial health indicators to avoid overextension.
• Risk Monitoring: As the sole director is also a significant controller, ensure robust risk management and succession planning to avoid single-person dependency risks.

---

Medical Analogy Summary:
SAS MEDICS LIMITED’s financial health is akin to a patient in recovery with stable vital signs and improving strength. The company shows no distress signals in liquidity or solvency, and with careful management, it can expect a favorable prognosis for growth and sustainability.

---